In May 2002, Schering-Plough agreed to pay a record $500m (€390m) fine after signing a decree to improve manufacturing standards at its facilities in Puerto Rico and New Jersey used for the production of its antihistamine Claritin (loratadine).
http://bobfiddaman.blogspot.com/2010/10/puerto-rico-defective-drugs-not-unique.html
No comments:
Post a Comment
Note: only a member of this blog may post a comment.